desvenlafaxine

Generic: desvenlafaxine

Labeler: preferred pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name desvenlafaxine
Generic Name desvenlafaxine
Labeler preferred pharmaceuticals inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

desvenlafaxine succinate 50 mg/1

Manufacturer
Preferred Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 68788-8760
Product ID 68788-8760_337771e1-3a8c-47e1-9c09-4df4abfaef3b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204028
Listing Expiration 2027-12-31
Marketing Start 2024-11-11

Pharmacologic Class

Classes
cytochrome p450 2d6 inhibitors [moa] norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687888760
Hyphenated Format 68788-8760

Supplemental Identifiers

RxCUI
1874559
UNII
ZB22ENF0XR

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name desvenlafaxine (source: ndc)
Generic Name desvenlafaxine (source: ndc)
Application Number ANDA204028 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-1)
  • 30 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-3)
  • 60 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-6)
  • 90 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-9)
source: ndc

Packages (4)

68788-8760-1 100 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-1) 68788-8760-3 30 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-3) 68788-8760-6 60 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-6) 68788-8760-9 90 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-9)

Ingredients (1)

desvenlafaxine succinate (50 mg/1)

Linked Drug Pages (1)

DESVENLAFAXINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "337771e1-3a8c-47e1-9c09-4df4abfaef3b", "openfda": {"unii": ["ZB22ENF0XR"], "rxcui": ["1874559"], "spl_set_id": ["5a136b61-f734-43d5-86fc-059ff3b5342a"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-1)", "package_ndc": "68788-8760-1", "marketing_start_date": "20241111"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-3)", "package_ndc": "68788-8760-3", "marketing_start_date": "20241111"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-6)", "package_ndc": "68788-8760-6", "marketing_start_date": "20241111"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-9)", "package_ndc": "68788-8760-9", "marketing_start_date": "20241111"}], "brand_name": "DESVENLAFAXINE", "product_id": "68788-8760_337771e1-3a8c-47e1-9c09-4df4abfaef3b", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "68788-8760", "generic_name": "DESVENLAFAXINE", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DESVENLAFAXINE", "active_ingredients": [{"name": "DESVENLAFAXINE SUCCINATE", "strength": "50 mg/1"}], "application_number": "ANDA204028", "marketing_category": "ANDA", "marketing_start_date": "20241111", "listing_expiration_date": "20271231"}